Minerva Neurosciences Statistics
Total Valuation
NERV has a market cap or net worth of $16.99 million. The enterprise value is -$24.02 million.
Market Cap | 16.99M |
Enterprise Value | -24.02M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NERV has 6.99 million shares outstanding. The number of shares has increased by 21.84% in one year.
Shares Outstanding | 6.99M |
Shares Change (YoY) | +21.84% |
Shares Change (QoQ) | +0.15% |
Owned by Insiders (%) | 22.26% |
Owned by Institutions (%) | 35.10% |
Float | 5.44M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.57
Current Ratio | 12.57 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -50.30% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.33M |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.29% in the last 52 weeks. The beta is 0.22, so NERV's price volatility has been lower than the market average.
Beta (1Y) | 0.22 |
52-Week Price Change | +4.29% |
50-Day Moving Average | 3.51 |
200-Day Moving Average | 6.43 |
Relative Strength Index (RSI) | 33.02 |
Average Volume (30 Days) | 120,867 |
Short Selling Information
The latest short interest is 30,475, so 0.44% of the outstanding shares have been sold short.
Short Interest | 30,475 |
Short Previous Month | 40,309 |
Short % of Shares Out | 0.44% |
Short % of Float | 0.56% |
Short Ratio (days to cover) | 1.25 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -23.12M |
Pretax Income | -30.01M |
Net Income | -30.01M |
EBITDA | -29.97M |
EBIT | -30.01M |
Earnings Per Share (EPS) | -$4.61 |
Balance Sheet
The company has $41.01 million in cash and no debt, giving a net cash position of $41.01 million or $5.86 per share.
Cash & Cash Equivalents | 41.01M |
Total Debt | n/a |
Net Cash | 41.01M |
Net Cash Per Share | $5.86 |
Equity / Book Value | -28.46M |
Book Value Per Share | -4.07 |
Working Capital | 38.66M |
Cash Flow
Operating Cash Flow | -14.78M |
Capital Expenditures | n/a |
Free Cash Flow | -14.78M |
FCF Per Share | -$2.27 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NERV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.84% |
Shareholder Yield | -21.84% |
Earnings Yield | -176.56% |
FCF Yield | -87.00% |
Analyst Forecast
The average price target for NERV is $11.00, which is 352.68% higher than the current price. The consensus rating is "Hold".
Price Target | $11.00 |
Price Target Difference | 352.68% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.
Last Split Date | Jun 21, 2022 |
Split Type | Reverse |
Split Ratio | 1:8 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |